Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07738445
Retreat-Based Program for Violence-Exposed Women VeteransVA Office of Research and DevelopmentNot Yet RecruitingPhase 2
NCT07738445Not Yet Recruiting
Phase 2
Retreat-Based Program for Violence-Exposed Women VeteransVA Office of Research and...
NCT07740538
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy UniversityNot Yet Recruiting
NCT07740538Not Yet Recruiting
—
Malnutrition and Sarcopenia Among Primary Ciliary DyskinesiaIzmir Democracy Universit...
NCT07738523
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB TrialHospital Universitario GetafeRecruitingPhase 2
NCT07738523Recruiting
Phase 2
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFI...Hospital Universitario Ge...
NCT07740200
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic StudyAap Ka ClinicCompleted
NCT07740200Completed
—
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician...Aap Ka Clinic
NCT07740512
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)Polaryx Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07740512Not Yet Recruiting
Phase 2
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in P...Polaryx Therapeutics, Inc...
NCT07739810
Miniaturized Vital Sign Monitoring for Newborns in the Delivery RoomMcGill University Health Centre/Research Institute of the McGill University Health CentreNot Yet Recruiting
NCT07739810Not Yet Recruiting
—
Miniaturized Vital Sign Monitoring for Newborns in the Delivery RoomMcGill University Health...
NCT07739823
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health Centre/Research Institute of the McGill University Health CentreNot Yet Recruiting
NCT07739823Not Yet Recruiting
—
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health...
NCT07739238
THE EFFECTS OF DIFFERENT BREATHING EXERCISES ON RESPIRATORY PARAMETERS AND HEART RATE VARIABILITYBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07739238Recruiting
Not Applicable
THE EFFECTS OF DIFFERENT BREATHING EXERCISES ON RESPIRATORY PARAMETERS AND HEART...Bandırma Onyedi Eylül Uni...
NCT07739290
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney InjuryBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07739290Not Yet Recruiting
Not Applicable
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute...Beth Israel Deaconess Med...
NCT07739589
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal SystemAgile TherapeuticsCompletedPhase 4
NCT07739589Completed
Phase 4
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Eth...Agile Therapeutics
NCT07738601
Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) StudyAssistance Publique Hopitaux De MarseilleNot Yet Recruiting
NCT07738601Not Yet Recruiting
—
Patient Reported Outcome Measurement Within the Secured Access to Innovative Med...Assistance Publique Hopit...
NCT07739160
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmaceuticals Co., LtdNot Yet RecruitingPhase 2
NCT07739160Not Yet Recruiting
Phase 2
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmace...
NCT07738510
Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring TransfusionsHalia Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07738510Not Yet Recruiting
Phase 2
Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplast...Halia Therapeutics, Inc.
NCT07739888
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNovartis PharmaceuticalsNot Yet RecruitingPhase 3
NCT07739888Not Yet Recruiting
Phase 3
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients Wi...Novartis Pharmaceuticals
NCT07738315
Elemene Liposomes in Endometrial CancerBeijing Friendship HospitalNot Yet RecruitingPhase 2
NCT07738315Not Yet Recruiting
Phase 2
Elemene Liposomes in Endometrial CancerBeijing Friendship Hospit...
NCT07738653
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion PodoactivaCompletedNot Applicable
NCT07738653Completed
Not Applicable
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion Podoactiva
NCT07739485
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding StudyLiu ShuNot Yet RecruitingPhase 1
NCT07739485Not Yet Recruiting
Phase 1
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A...Liu Shu
NCT07738861
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Molar ExtractionCMH Lahore Medical College and Institute of DentistryCompletedPhase 4
NCT07738861Completed
Phase 4
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Mol...CMH Lahore Medical Colleg...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07739095
Weight Loss and HungerCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
Result Breakdown
Not yet recruiting13 (65%)
Completed5 (25%)
Recruiting2 (10%)
Phase 26 (30%)
Not Specified5 (25%)
not_applicable5 (25%)
Phase 42 (10%)
Phase 31 (5%)
Phase 11 (5%)